Anti-ERBB1/EGFR/HER1 Antibody (Nimotuzumab)
Catalog No.
F1424
Anti-ERBB1/EGFR/HER1 Antibody (Nimotuzumab)
Featured Products
Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab targets the extracellular domain of EGFR and blocks its binding to its ligand. Nimotuzumab is a potent anti-tumor active molecule that has a cytolytic effect on target tumors through its ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
147.58 kDa
Dry ice
828933-51-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Theracim, Theraloc, BIOMAb EGFR
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P00533
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ERBB1 / EGFR / HER1
Please avoid freeze-thaw cycles.